Skip to main content
. 2018 May 22;2018(5):CD011977. doi: 10.1002/14651858.CD011977.pub2

Yuan 2004.

Methods Study design: RCT
Study grouping: parallel group, with one eye per participant randomised to one of the interventions
Exclusions after randomisation: a total of 60 participants were originally randomised; the blue‐light filtering IOL group included 27 individuals (12 men, 15 women; as three patients were non‐compliant). No further details were provided.
Losses to follow‐up: not reported
How missing data were handled: not reported
Reported power size calculation? no
Participants Baseline characteristics
Blue‐light filtering IOL group
  • Number of participants: number of people (number of eyes): 27 (27)

  • Sex (number of women/number of men): 15/12

  • Age (mean): 70.33 years (unit of error not specified)


Non‐blue‐light filtering IOL group
  • Number of participants: number of people (number of eyes): 30 (30)

  • Sex (number of women/number of men): 16/14

  • Age (mean): 67.06 years (unit of error not specified)


Inclusion criteria: people with senile cataract
Exclusion criteria: not reported
Comparison of study groups at baseline: there was no significant difference in visual acuities (0.80–1.02) between the yellow UV and ordinary UV IOL groups (P > 0.05) (note: it was unclear if this was at baseline or postoperative)
Interventions Intervention characteristics
Blue‐light filtering IOL
  • Type of IOL: Hoya lens (not specified)


Non‐blue‐light filtering IOL
  • Type of IOL: not reported

Outcomes Visual acuity, spatial contrast sensitivity (Stereo Optical, Chicago, Illinois, U.S.A.), colour vision (FM‐100, Munsell, New Windsor, New York, U.S.A.), and subjective sensation at one week to six months postoperatively
Participants were questioned about photophobia and cyanopsia.
Identification Sponsorship source:
Funding sources: not reported
Declaration of interest: not reported
Country: China
Setting: Tianjin Medical University Eye Center
Comments:
Date study conducted: not reported
Trial registration number: not reported
Contacting study investigators: authors contacted on 14 August 2017 regarding the contrast sensitivity outcome unit of error; no response was received to this email, and as a result we could not include these data in the meta‐analysis
First author's name: Zhaoxu Yuan, MD, PhD
Institution: Medical Research Building, Scottand White Hospital
Email: zyuan@tamu.edu
Corresponding author's address:
Zhaoxu Yuan
Medical Research Building, Scottand White Hospital
702 SW HK Dodgen Loop, Temple, TX, USA 76504
Notes None
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Judgement comment: not reported how list was generated. Study is described as “randomised” but with no further details
Allocation concealment (selection bias) Unclear risk Judgement comment: not reported how allocation administered. Study is described as “randomised” but with no further details
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Judgement comment: no information provided on masking. We assume that in absence of reporting on this, participants and personnel were not masked.
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Judgement comment: no information provided on masking. We assume that in absence of reporting on this, outcome assessors were not masked.
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Judgement comment: follow‐up not reported, although three participants in the blue‐light blocking IOL group were reported to be "non‐compliant" and appear to have been excluded from the analyses
Selective reporting (reporting bias) Unclear risk Judgement comment: no access to protocol or trials registry entry
Other bias Low risk Judgement comment: no other apparent sources of bias

AAO: American Academy of Ophthalmology
 AMD: age‐related macular degeneration
 ARVO: Association for Research in Vision and Ophthalmology
 BCVA: best‐corrected visual acuity
 BMI: body mass index
 D: dioptre
 HRQoL: health‐related quality of life
 IOL: intraocular lens
 RCT: randomised controlled trial
 UCVA: uncorrected visual acuity